UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 9
September-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2309498


Registration ID:
525224

Page Number

e800-e813

Share This Article


Jetir RMS

Title

DESIGN AND DEVELOPMENT OF A MICROPARTICLE BASED INHALATION FORMULATION OF ANTIASTHMATIC DRUG BY QbD APPROACH

Abstract

The method of solvent evaporation was chosen as it is a well-established technique for producing inhalable microparticles with controlled drug release properties. By using this method, we aimed to encapsulate Salbutamol Sulphate within biocompatible polymers, ensuring its stability and enhancing its therapeutic efficacy. S.S. microparticles are created by employing the biodegradable polymer PEG (poly ethylene glycol).The ability to effectively aerosolize different inhalable Salbutamol Sulphate formulations with appropriate (MMAD) mass median aerodynamic diameter 3.32& fraction of fine particles (FPF) ranging up to 62.40%. According to ICH requirements, stability tests on the improved formulations were conducted done with a relative humidity of 75% at a temperature of 40 °C. The % CDR at 12 hours was shown by the optimised batch F9 (85.32%). The optimised batch F9 had an average particle size of 3.06µm and kinetic models displays Fickian diffusion kinetics. The stability investigation on the improved batch F9, conducted in accordance with ICH criteria, revealed no appreciable change in the drug composition. These findings effectively showed that respirable microparticles made from salbutamol sulphate could be created, making them a promising delivery method for the quick and efficient treatment of COPD.

Key Words

Salbutamol Sulphate, PEG, Meg, Solvent evaporation method.

Cite This Article

"DESIGN AND DEVELOPMENT OF A MICROPARTICLE BASED INHALATION FORMULATION OF ANTIASTHMATIC DRUG BY QbD APPROACH", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 9, page no.e800-e813, September-2023, Available :http://www.jetir.org/papers/JETIR2309498.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"DESIGN AND DEVELOPMENT OF A MICROPARTICLE BASED INHALATION FORMULATION OF ANTIASTHMATIC DRUG BY QbD APPROACH", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 9, page no. ppe800-e813, September-2023, Available at : http://www.jetir.org/papers/JETIR2309498.pdf

Publication Details

Published Paper ID: JETIR2309498
Registration ID: 525224
Published In: Volume 10 | Issue 9 | Year September-2023
DOI (Digital Object Identifier):
Page No: e800-e813
Country: MANDYA, Karnataka, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00057

Print This Page

Current Call For Paper

Jetir RMS